These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
338 related articles for article (PubMed ID: 27916840)
41. The Role of TAM Receptors in Bone. Engelmann J; Ragipoglu D; Ben-Batalla I; Loges S Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203403 [TBL] [Abstract][Full Text] [Related]
42. Myeloid cell-derived PROS1 inhibits tumor metastasis by regulating inflammatory and immune responses via IL-10. Maimon A; Levi-Yahid V; Ben-Meir K; Halpern A; Talmi Z; Priya S; Mizraji G; Mistriel-Zerbib S; Berger M; Baniyash M; Loges S; Burstyn-Cohen T J Clin Invest; 2021 May; 131(10):. PubMed ID: 33848267 [TBL] [Abstract][Full Text] [Related]
43. Coordinated expression of tyro3, axl, and mer receptors in macrophage ontogeny. Malawista A; Wang X; Trentalange M; Allore HG; Montgomery RR Macrophage (Houst); 2016; 3():. PubMed ID: 27695708 [TBL] [Abstract][Full Text] [Related]
44. Growth Arrest-Specific Factor 6 (GAS6) Is Increased in COVID-19 Patients and Predicts Clinical Outcome. Morales A; Rojo Rello S; Cristóbal H; Fiz-López A; Arribas E; Marí M; Tutusaus A; de la Cal-Sabater P; Nicolaes GAF; Ortiz-Pérez JT; Bernardo D; García de Frutos P Biomedicines; 2021 Mar; 9(4):. PubMed ID: 33810394 [TBL] [Abstract][Full Text] [Related]
45. Dysregulation of TLR5 and TAM Ligands in the Alzheimer's Brain as Contributors to Disease Progression. Herrera-Rivero M; Santarelli F; Brosseron F; Kummer MP; Heneka MT Mol Neurobiol; 2019 Sep; 56(9):6539-6550. PubMed ID: 30852796 [TBL] [Abstract][Full Text] [Related]
46. Immune Evasion Mechanism and AXL. Son HY; Jeong HK Front Oncol; 2021; 11():756225. PubMed ID: 34778071 [TBL] [Abstract][Full Text] [Related]
47. Targeting MERTK and AXL in Yan D; Earp HS; DeRyckere D; Graham DK Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830794 [TBL] [Abstract][Full Text] [Related]
49. Vitamin K-dependent actions of Gas6. Bellido-Martín L; de Frutos PG Vitam Horm; 2008; 78():185-209. PubMed ID: 18374195 [TBL] [Abstract][Full Text] [Related]
50. Immuno-oncology: are TAM receptors in glioblastoma friends or foes? Zhou Y; Wang Y; Chen H; Xu Y; Luo Y; Deng Y; Zhang J; Shao A Cell Commun Signal; 2021 Jan; 19(1):11. PubMed ID: 33509214 [TBL] [Abstract][Full Text] [Related]
51. Gas6/TAM Axis in Sepsis: Time to Consider Its Potential Role as a Therapeutic Target. Salmi L; Gavelli F; Patrucco F; Caputo M; Avanzi GC; Castello LM Dis Markers; 2019; 2019():6156493. PubMed ID: 31485279 [TBL] [Abstract][Full Text] [Related]
52. GAS6 and AXL Promote Insulin Resistance by Rewiring Insulin Signaling and Increasing Insulin Receptor Trafficking to Endosomes. Schott C; Germain A; Lacombe J; Pata M; Faubert D; Boulais J; Carmeliet P; Côté JF; Ferron M Diabetes; 2024 Oct; 73(10):1648-1661. PubMed ID: 39046834 [TBL] [Abstract][Full Text] [Related]
53. The TAM receptor Tyro3 regulates myelination in the central nervous system. Akkermann R; Aprico A; Perera AA; Bujalka H; Cole AE; Xiao J; Field J; Kilpatrick TJ; Binder MD Glia; 2017 Apr; 65(4):581-591. PubMed ID: 28145605 [TBL] [Abstract][Full Text] [Related]
54. Gas6/TAM System: A Key Modulator of the Interplay between Inflammation and Fibrosis. Bellan M; Cittone MG; Tonello S; Rigamonti C; Castello LM; Gavelli F; Pirisi M; Sainaghi PP Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31614787 [TBL] [Abstract][Full Text] [Related]
55. TAM receptor signalling and demyelination. Binder MD; Kilpatrick TJ Neurosignals; 2009; 17(4):277-87. PubMed ID: 19816064 [TBL] [Abstract][Full Text] [Related]
57. The AXL Receptor is a Sensor of Ligand Spatial Heterogeneity. Meyer AS; Zweemer AJ; Lauffenburger DA Cell Syst; 2015 Jul; 1(1):25-36. PubMed ID: 26236777 [TBL] [Abstract][Full Text] [Related]
58. TAM receptor deficiency affects adult hippocampal neurogenesis. Ji R; Meng L; Li Q; Lu Q Metab Brain Dis; 2015 Jun; 30(3):633-44. PubMed ID: 25487541 [TBL] [Abstract][Full Text] [Related]
59. The Dual Role of TAM Receptors in Autoimmune Diseases and Cancer: An Overview. Wium M; Paccez JD; Zerbini LF Cells; 2018 Oct; 7(10):. PubMed ID: 30322068 [TBL] [Abstract][Full Text] [Related]
60. The Development of AXL Inhibitors in Lung Cancer: Recent Progress and Challenges. Sang YB; Kim JH; Kim CG; Hong MH; Kim HR; Cho BC; Lim SM Front Oncol; 2022; 12():811247. PubMed ID: 35311091 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]